Anti-TNF-Î± therapy for orofacial granulomatosis: proceed with caution
- Tactile threshold and pressure pain threshold during treatment of orofacial pain: an explorative study. Drobek, Wojciech; de Laat, Antoon; Schoenaers, Joseph // Clinical Oral Investigations;Sep2001, Vol. 5 Issue 3, p185
The aim of the present study was to evaluate the pressure pain threshold (PPT), tactile threshold (TT) and pain intensity as measured on a Visual Analogue Scale (VAS) in patients with pain in the orofacial region. Twenty-six patients with myogenous pain (7 ss), myogenous and capsular pain (11...
- EDITORIAL. Pećina, Marko // Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanost;2012, Vol. 511 Issue 38, p7
An introduction to this issue is presented, which contains papers from the symposium entitled "Modern Knowledge on Orofacial Diseases in Croatia" that was held in November 18, 2011.
- Continuing Medical Education Questions: Supplement 1, April 2011. DeVault, Kenneth R. // American Journal of Gastroenterology;Apr2011 Supplement, Vol. 106, pS26
A quiz concerning the treatment for inflammatory bowel disease (IBD) is presented.
- SOFT STOOLS, SOFT BONES AND SOFT EVIDENCE?â€”WHAT INFLAMMATORY BOWEL DISEASE PATIENT THINK OF OSTEOPOROSIS MEDICATION. Oliver, D.G.; Trewby, P.N. // Gut;Apr2003 Supplement 1, Vol. 52, pA70
Background: The British Society of Gastroenterology guidelines for osteoporosis in inflammatory bowel disease imply the screening of a large proportion of inflammatory bowel disease patients and treatment with antiresorptive medication if necessary. Despite this, only a small percentage of...
- Lymphangiectatic oro-facial and ano-genital granulomatosis. Its relationship with Crohn's disease. Salerno, V.; Mangione, A.; Garofalo, L.; Bonifazi, E. // European Journal of Pediatric Dermatolgy;2012, Vol. 22 Issue 4, p263
Oro-facial and ano-genital granulomatosis represent two aspects of the same chronic inflammatory disorder probably related with Crohn's disease. In this paper we describe three pediatric cases of granulomatosis, one oro-facial and two ano-genital; the second of these two cases was followed after...
- Management of cutaneous disorders related to inflammatory bowel disease. Pellicer, Zaira; Santiago, Jesus Manuel; Rodriguez, Alejandro; Alonso, Vicent; Bosca, Marta Maia // Annals of Gastroenterology;Jan2012, Vol. 25, p21
Almost one-third of patients with inflammatory bowel disease (IBD) develop skin lesions. Cutaneous disorders associated with IBD may be divided into 5 groups based on the nature of the association: specific manifestations (orofacial and metastatic IBD), reactive disorders (erythema nodosum,...
- Isotretinoin and Risk of Inflammatory Bowel Disease. Dai, Cong; Jiang, Min; Sun, Ming-Jun // American Journal of Gastroenterology;Sep2014, Vol. 109 Issue 9, p1493
A letter to the editor is presented in response to the article "Isotretinoin and risk of inflammatory bowel disease: A French Nationwide Study" by Racine A and colleagues in the 2014 issue of the journal.
- Response to Dai et al. Racine, Antoine; Boutron-Ruault, Marie-Christine; Carbonnel, Franck // American Journal of Gastroenterology;Sep2014, Vol. 109 Issue 9, p1494
A response from the author of the article "Isotretinoin and risk of inflammatory bowel disease: A French nationwide study" in the 2014 issue of the journal is presented.
- Antibacterials linked to IBD. // Reactions Weekly;10/22/2011, Issue 1374, p4
The article reports on a study which found that adult-onset inflammatory bowel disease (IBD) is significantly associated with antibacterial therapy in the 2-5 years before diagnosis.